Race against time: which drug stops Kids' dangerous seizures faster?
NCT ID NCT07163572
Summary
This study compared two intravenous medications—brivaracetam and levetiracetam—for stopping prolonged, dangerous seizures (status epilepticus) in children. Researchers tested which drug worked better and was safer for children aged 1 month to 16 years during these medical emergencies. The goal was to help doctors choose the most effective treatment quickly when every minute counts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STATUS EPILEPTICUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Children's Hospital and Institute of Child Health
Multan, Punjab Province, 66000, Pakistan
Conditions
Explore the condition pages connected to this study.